Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 219-154-7 | CAS number: 2374-14-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Dermal absorption
Administrative data
- Endpoint:
- dermal absorption in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 6 February to 16 April 2014
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 015
- Report date:
- 2015
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 428 (Skin Absorption: In Vitro Method)
- Deviations:
- no
- GLP compliance:
- yes
Test material
- Reference substance name:
- 2,4,6-trimethyl-2,4,6-tris(3,3,3-trifluoropropyl)cyclotrisiloxane
- EC Number:
- 219-154-7
- EC Name:
- 2,4,6-trimethyl-2,4,6-tris(3,3,3-trifluoropropyl)cyclotrisiloxane
- Cas Number:
- 2374-14-3
- Molecular formula:
- C12H21F9O3Si3
- IUPAC Name:
- 2,4,6-trimethyl-2,4,6-tris(3,3,3-trifluoropropyl)cyclotrisiloxane
- Reference substance name:
- 2, 4, 6-trimethyl-2, 4, 6-tris(3, 3, 3-trifluoropropyl)cyclotrisiloxane
- IUPAC Name:
- 2, 4, 6-trimethyl-2, 4, 6-tris(3, 3, 3-trifluoropropyl)cyclotrisiloxane
- Test material form:
- other: liquid
Constituent 1
Constituent 2
- Radiolabelling:
- yes
Test animals
- Species:
- other: in vitro rabbit skin
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Rabbit skin was obtained from Bioreclamation LLC, USA. Skin was from 2 male and 2 female New Zealand White rabbits approximately 3 months of age
Administration / exposure
- Type of coverage:
- semiocclusive
- Vehicle:
- unchanged (no vehicle)
- Duration of exposure:
- 24 hours
- Doses:
- approx 10mg/cm2 (or 7mg/0.64cm2)
- No. of animals per group:
- Triplicate skin samples each from 4 rabbits
- Control animals:
- no
- Details on in vitro test system (if applicable):
- SKIN PREPARATION
- Source of skin: Bioreclamation LLC, USA
- Type of skin: rabbit
- Preparative technique:
On the day of experiment, skins were thawed at room temperature and underlying fat removed. Excessive hairs were removed with an electric clipper and skin sections (samples) of appropriate thickness (200-500 microns) were prepared. Prepared skin membrane from each subject was placed in labelled petri dishes, one for each individual rabbit subject, containing cell culture medium at room temperature while the other skin sections were being processed. Skin sections free of blemishes and of the appropriate thickness were chosen from each subject. Three disc shaped pieces, large enough to fit 0.64cm2 flow-through diffusion cells, were punched out from each skin sample and rinsed with water. the thickness of all skin pieces was measured with a digimatic micrometer before placing each piece epidermis side up in the diffusion flow-through cells.
- Thickness of skin (in um): 200-500
- Membrane integrity check:
Each piece of skin received and infinite dose of 3H-H20 (~200ul, exact dose determined gravimetrically) for 20 minutes in order to determine if the barrier integrity of the skin had been compromised. The 3H-H20 was diluted to obtain specific gravity of ~ 0.000893mCi/g (1982 disintegrations per minute/mg, DPM/mg) using analytical grade water.
The 3H-H20 dose was removed by blotting the skin surface after 20 minutes of exposure and skin was rinsed with reverse osmosis water (analytical grade water) and dried by gentle blotting. Aliquots of the receptor fluid were continued to be collected for an additional 60 minutes after the dose was removed. Radioactivity content in the receptor fluid was determined by liquid scintillation analysis.
- Storage conditions: shipped on dry ice and stored frozen at -20 degrees C
PRINCIPLES OF ASSAY
- Receptor fluid: HBSS-Hank's Balanced Salt Solution with 0.6% HEPES, 0.005% Gentamicin and 4% Bovine Serum Albumin was mixed, the pH was adjusted to 7.3 - 7.5 with 1N NaOH and then filtered through a 0.45 micron filter. The receptor fluid was pumped beneath the skin samples through the receptor compartment for 24 hours at a flow rate between 2.0 - 2.5 ml/hr and collected using a fraction collector.
- Solubility of test substance in receptor fluid: Approximately 10.0 ml of the receptor fluid containing 4% Bovine Serum Albumin was placed in a specially designed flask with a sampling port at the bottom. The 14C test article (10mg) was spiked onto the surface of the receptor fluid. Receptor fluid aliquots were taken from the bottom of the flask via the sampling port at 1 and 2 hours and radioactivity content analysed by liquid scintillation counter. Data showed that 14C test article migrated from the surface into the receptor fluid reaching a concentration of 0.57 ppm in 2 hours. This concentration represents >1000-fold increase in solubility relative to the water solubility of trifluoropropylmethylcyclotrisiloxane (0.0013 ppb). Also, 0.19% of applied 14C test article was recovered in receptor fluid with 2 hours demonstrating that solubility of the test article was higher than the amount of test article penetrated into the receptor fluid over 24 hours of skin exposure (average 0.098% of applied dose).
- Flow-through system: Bronaugh flow-through apparatus
- Test temperature: not stated
- Humidity: not stated
- Occlusion: no
Results and discussion
- Signs and symptoms of toxicity:
- not examined
- Dermal irritation:
- not examined
Percutaneous absorption
- Dose:
- 10 mg/cm2
- Parameter:
- percentage
- Absorption:
- 0.098 %
- Remarks on result:
- other: entire 24 hour period
Any other information on results incl. tables
The average dose applied to the skin sample was 0.00742g by syringe dose measurement (Table 1).
Table 1: determination of Dose (Syringe dose gravimetric)
Trial |
Syringe + Dose Solution weight (g) |
Empty Syringe weight (g) |
Dose weight (g) |
1 |
8.3017 |
8.2943 |
0..074 |
2 |
8.3033 |
8.2954 |
0.0079 |
3 |
8.3030 |
8.2957 |
0.0073 |
4 |
8.3031 |
8.2958 |
0.0073 |
5 |
8.3031 |
8.2960 |
0.0071 |
6 |
8.3030 |
8.2957 |
0.0073 |
7 |
8.3034 |
8.2959 |
0.0075 |
8 |
8.3032 |
8.2959 |
0.0073 |
9 |
8.3032 |
8.2957 |
0.0075 |
10 |
8.3037 |
8.2961 |
0.0076 |
Mean |
|
|
0.00742 |
A small amount of 14C-test article penetrated through the skin into the receptor fluid (0.098% of applied dose +/- 0.01) over the 24 hour exposure period (Table 2). The mean cumulative penetration of radioactivity over the 24 hour period was 30009.51 +/- 2954.86 DPM/cm2 of skin and 1.125 +/- 0.111 µg equivalent cm2 skin (Table 3). Permeability coefficient (Kp) was estimated to be 0.000122 cm/hr based on steady state flux established between 1 and 5 hours.
The percent of applied 14C-test article recovered from all analysed samples was 92.63% +/- 4.2 (Table 2). The majority of the applied dose was found on the skin surface from the exposure site (62.55% +/- 5.27) and in the skin (29.36% +/- 6.97). Only 0.629% +/- 0.223 of applied dose was found on the PorPak-P tubes and the part of the apparatus specifically designed to hold them. The total percent dose absorbed was estimated to be 29.45% +/- 6.67 of applied dose with virtually all of the absorbed 14C retained in the skin after washing and tape stripping of the exposure site.
Table 2: in vitro disposition of radioactivity following application of 14C-test article to rabbit skin
Dose Solution |
Skin Surface (%) |
Volatilized Dose (%) |
Skin |
Penetrated |
Absorbed (%) |
Total Dose Recovery (%) |
14C |
62.55 |
0.629 |
29.36 |
0.098 |
29.45 |
92.63 |
SEM |
5.27 |
0.223 |
6.97 |
0.01 |
6.43 |
4.2 |
Table 3: Cumulative penetration of 14C-test article through rabbit skin
Cell No. |
Skin subject |
Cumulative DPM/cm2 skin |
Mean cumulative DPM/cm2 skin |
SD |
SEM |
Cumulative µg equiv./cm2skin |
Mean Cumulative µg equiv./cm2skin |
SEM |
SD |
1 |
A |
28894.16 |
|
|
|
10.83 |
|
|
|
2 |
A |
30508.84 |
|
|
|
11.43 |
|
|
|
3 |
A |
33384.05 |
30929.01 |
2274.24 |
1313.04 |
12.51 |
11.59 |
0.49 |
0.85 |
4 |
B |
28234.72 |
|
|
|
10.58 |
|
|
|
5 |
B |
28358.89 |
|
|
|
10.63 |
|
|
|
6 |
B |
38419.14 |
31670.91 |
5844.46 |
3374.30 |
14.40 |
11.87 |
1.26 |
2.19 |
7 |
C |
43482.07 |
|
|
|
16.29 |
|
|
|
8 |
C |
22911.55 |
|
|
|
8.59 |
|
|
|
9# |
C |
|
33196.81 |
14545.55 |
10285.26 |
|
12.44 |
3.85 |
5.45 |
10 |
D |
16354.17 |
|
|
|
6.13 |
|
|
|
11 |
D |
44819.91 |
|
|
|
16.80 |
|
|
|
12 |
D |
14737.16 |
25303.75 |
16920.82 |
9769.24 |
5.52 |
9.48 |
3.66 |
6.34 |
Mean |
|
30009.51 |
|
|
|
11.25 |
|
|
|
# Cell No. 9 was excluded due to skin integrity test.
Applicant's summary and conclusion
- Conclusions:
- The study demonstrated that large amounts of 14C-trifluoropropylmethylcyclotrisiloxane was recovered from the skin surface (62.55% of applied dose) after a 24 hour exposure period or remained in the skin after washing and tape stripping (29.36 % of applied dose). Only a small amount of dose (0.63% of applied dose) volatilized from the skin surface. The percent of applied dose of 14C-trifluoropropylmethylcyclotrisiloxane recovered from all analysed samples was 92.63%. Little (0.098%) of the applied dose penetrated through the skin into the receptor fluid with the mean cumulative penetration (+/- SEM) over 24 hours being only 11.25 +/- 1.11 µg equivalents 14C-trifluoropropylmethylcyclotrisiloxane per cm2 exposed skin.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.